Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease.

Authors :: Weile, Jan
Seibold, Erik
Knabbe, Cornelius
Kaufmann, Martin
Splettstoesser, Wolf
Source :: Emerging Infectious Diseases. May2013, Vol. 19 Issue 5, p771-773. 3p. 1 Chart.
Publication Year :: 2013
Abstract: We describe a case of human tularemia caused by Francisella tularensis subsp. holarctica in a stem cell transplant recipient with chronic graft-versus-host disease who was receiving levofloxacin prophylaxis. The infection was characterized by pneumonia with septic complications. The patient was successfully treated with doxycycline. [ABSTRACT FROM AUTHOR]